Condition
Pain secondary to chemotherapy-induced peripheral neuropathy
Total Trials
1
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Ozone
Research Leaders
8 sponsors active, led by Red de Investigación en Servicios de Salud en Enfermedades Crónicas
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 2/3 (1)
Trial Status
Recruiting1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Ozone1
- Oxygen1
Active Sponsors
- Red de Investigación en Servicios de Salud en Enfermedades Crónicas1
- Fundación Española del Dolor (FED)1
- Instituto de Salud Carlos III1
- Fundación DISA, Spain1
- Council of Gran Canaria1
Top Investigators
Dr. Negrín University Hospital, Las Palmas, Spain
Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas, Spain
Institute for Applied Microelectronics, University of Las Palmas de G. C., Spain
Servicio de Evaluación. Servicio Canario de Salud. Spain
Related Conditions
- Chemotherapyinduced Peripheral Neuropathy1
- Pain Syndrome1
- Pain Neuropathic1